Skip to main content

On the precipice of an impending avalanche of regulatory compliance activity: Are you prepared?

The COVID-19 pandemic brought into sharp focus the vulnerabilities in supply chains for medical products and the importance of ensuring their integrity to provide patient access to critical products. This historical event has also engendered an unprecedented pace in developing, testing, and producing COVID-19 tests, treatments, and vaccines – and triggered extraordinary flexibility among regulatory authorities. However, this flexibility could have unintended consequences for medical product manufacturing and testing facilities.